- Home
- CNTA vs ZD Comparison
CNTA vs ZD Comparison
Compare CNTA & ZD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- ZD
- Stock Information
- Founded
- CNTA 2020
- ZD 1995
- Country
- CNTA United Kingdom
- ZD United States
- Employees
- CNTA N/A
- ZD N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- ZD Advertising
- Sector
- CNTA Health Care
- ZD Consumer Discretionary
- Exchange
- CNTA Nasdaq
- ZD Nasdaq
- Market Cap
- CNTA 2.3B
- ZD N/A
- IPO Year
- CNTA 2021
- ZD 1999
- Fundamental
- Price
- CNTA $17.50
- ZD $54.78
- Analyst Decision
- CNTA Strong Buy
- ZD Buy
- Analyst Count
- CNTA 7
- ZD 8
- Target Price
- CNTA $23.71
- ZD $70.50
- AVG Volume (30 Days)
- CNTA 581.0K
- ZD 474.0K
- Earning Date
- CNTA 11-12-2024
- ZD 02-19-2025
- Dividend Yield
- CNTA N/A
- ZD N/A
- EPS Growth
- CNTA N/A
- ZD 41.38
- EPS
- CNTA N/A
- ZD 1.38
- Revenue
- CNTA $6,853,000.00
- ZD $1,378,750,000.00
- Revenue This Year
- CNTA N/A
- ZD $6.74
- Revenue Next Year
- CNTA N/A
- ZD $5.56
- P/E Ratio
- CNTA N/A
- ZD $39.75
- Revenue Growth
- CNTA N/A
- ZD 0.58
- 52 Week Low
- CNTA $6.65
- ZD $37.76
- 52 Week High
- CNTA $18.97
- ZD $70.90
- Technical
- Relative Strength Index (RSI)
- CNTA 53.43
- ZD 43.15
- Support Level
- CNTA $15.45
- ZD $53.62
- Resistance Level
- CNTA $18.00
- ZD $56.97
- Average True Range (ATR)
- CNTA 1.14
- ZD 1.87
- MACD
- CNTA -0.05
- ZD -0.55
- Stochastic Oscillator
- CNTA 76.78
- ZD 18.53
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.